Emre S, Umman V
Yale University School of Medicine, New Haven, CT, USA.
Transplant Proc. 2011 Apr;43(3):884-7. doi: 10.1016/j.transproceed.2011.02.036.
Liver transplantation (OLT) has become the only treatment modality for patients with end-stage liver diseases. Establishment of standard liver transplantation technique, development of better immunosuppressive medications and accumulated experience using them safely, and improvement of intensive care and anesthesia played major role to have current 88%-90% 1-year survival after liver transplantation. As liver transplantations became more successful with the growing experience and development in the field, the increased demand for liver allografts could not match the available supply of donor organs. As a result of this imbalance, each year nearly 3000 patients die in the United States awaiting liver transplantation on the national waiting list. Split liver transplantation (SLT) has been perceived as an important strategy to increase the supply of liver grafts by creating 2 transplants from 1 allograft. The bipartition of a whole liver also carries utmost importance by increasing the available grafts for the pediatric patients, where size-matched whole liver allografts are scarce, leading increased incidence of waiting list mortality in this group. In the common approach of the split liver procedure, liver is divided into a left lateral segment graft (LLS) to be transplanted to a child and a right extended liver lobe graft for an adult recipient. In a technically more challenging variant of this procedure, the principle is to split the liver into 2 hemigrafts and use the left side for a small adult or a teenager and the right for a medium-sized adult patient. Donor selection for splitting, technical expertise in both OLT and hepatobiliary surgery, logistics to decrease total ischemia time, and manpower of the transplantation team are important factors for successful outcomes after SLT. The liver can be split on the back table (ex situ) or in the donor hospital before the donor cross-clamp using in situ splitting technique, which was developed directly from living donor liver transplantation. The most important advantage of in situ splitting is to decrease the total ischemia time and increased the possibility of inter-center sharing. The in situ technique of splitting has other advantages, including evaluation of the viability of segment IV in case of LLS splitting and better control of bleeding from cut surface upon reperfusion on the recipient. Recipient selection for split liver grafts is also crucial for success after SLT. In this review, we aim to summarize the advances that have occurred in SLT. We also discuss anatomic and technical aspects, including both approaches to SLT, which is now considered by many centers to be a routine operation.
肝移植(OLT)已成为终末期肝病患者的唯一治疗方式。标准肝移植技术的建立、更好的免疫抑制药物的研发以及安全使用这些药物所积累的经验,还有重症监护和麻醉技术的改进,对目前肝移植术后1年生存率达到88% - 90%起到了主要作用。随着肝移植领域经验的不断积累和技术的发展,肝移植手术越来越成功,但对同种异体肝移植的需求增加却无法与供体器官的可用供应相匹配。由于这种不平衡,在美国,每年有近3000名患者在全国等待肝移植的名单上死亡。劈离式肝移植(SLT)被视为一种重要策略,通过将一个移植物分成两个移植物来增加肝移植物的供应。对于小儿患者来说,大小匹配的全肝移植物稀缺,全肝二分法对于增加可用于他们的移植物数量也极为重要,这导致该群体在等待名单上的死亡率上升。在劈离式肝移植手术的常见方法中,肝脏被分为一个左外侧叶移植物(LLS)用于移植给儿童,以及一个右扩展肝叶移植物用于成年受者。在该手术技术要求更高的一种变体中,原则是将肝脏劈成两个半肝移植物,左侧用于小成年人或青少年,右侧用于中等身材的成年患者。供体劈离的选择、OLT和肝胆外科的技术专长、减少总缺血时间的后勤保障以及移植团队的人力,都是SLT术后取得成功的重要因素。肝脏可以在手术台后(体外)劈离,或者在供体医院使用直接源自活体供肝移植的原位劈离技术在供体肝脏夹闭前进行劈离。原位劈离的最重要优势是减少总缺血时间并增加中心间共享的可能性。原位劈离技术还有其他优势,包括在劈离LLS时评估IV段的活力,以及在受者再灌注时更好地控制切面出血。劈离式肝移植移植物的受者选择对于SLT术后的成功也至关重要。在本综述中,我们旨在总结SLT所取得的进展。我们还将讨论解剖学和技术方面,包括SLT的两种方法,现在许多中心都认为这是一种常规手术。